News
Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...
Researchers analyzed data from the US Collaborative Network of TriNetX of 140,308 patients with T2D who were initiated on tirzepatide or a GLP-1 RA between June 1, 2022, and June 30, 2023.
A new study suggests that eating more protein while taking GLP-1 medications could help prevent muscle loss, a common side ...
A new study has found that a diabetes medicine called tirzepatide can help people lower their blood sugar and lose weight ...
Tirzepatide outperformed semaglutide in simultaneously achieving four key therapeutic targets for type 2 diabetes.
In addition, tirzepatide, at the same dose, demonstrated the highest weight-lowering efficacy, even in comparison to high-dosage GLP-1 receptor agonists (such as semaglutide 2.0 mg MD −7.0 kg ...
Adults with overweight or obesity lost more weight with the GIP/GLP-1 dual agonist tirzepatide than the GLP-1 receptor agonist semaglutide, according to findings published in JAMA Internal Medicine.
Adults with overweight or obesity lost more weight with the GIP/GLP-1 dual agonist tirzepatide than the GLP-1 receptor agonist semaglutide, according to findings published in JAMA Internal ...
Tirzepatide includes blockbuster injected GLP-1 medications Mounjaro (for diabetes) and Zepbound (for weight loss). The FDA first announced 2 months ago that any shortage of the medications ...
The resolution of shortages for tirzepatide and other GLP-1 medications, such as semaglutide, signals a potential shift toward increased FDA enforcement as the agency works to align industry ...
Tirzepatide includes blockbuster injected GLP-1 meds Mounjaro (for diabetes) and Zepbound (for weight loss). The FDA first announced two months ago that any shortage of the meds observed during ...
Tirzepatide includes blockbuster injected GLP-1 medications Mounjaro (for diabetes) and Zepbound (for weight loss). The FDA first announced two months ago that any shortage of the medications ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results